People with obesity and type 2 diabetes are at high risk of blood vessel damage. This risk depends not only on the genes a person carries, but also on how they are “read”. By changing the epigenetic ...

Is your check engine light on? Before you panic over a massive repair bill, discover the five most common faults triggering ...

A Boston biotech company has administered what researchers are describing as the first human dose of a cellular rejuvenation drug, a milestone in the effort to treat age-related disease at the ...

Proprietary Synthetic Polynucleotide Platform Accelerates Non-Viral, Footprint-Free Induced Pluripotent Stem Cell Generation Amid Surging Commercialization of iPSC Therapies in Japan SEATTLE, June 16, ...

Modern glaucoma treatments can only preserve a patient’s current level of vision, offering no hope of restoration. A new Phase 1 clinical trial is using gene therapy that could turn back the clock on ...

SEATTLE, June 16, 2026 (GLOBE NEWSWIRE) -- Pluristyx, a leading provider of advanced induced pluripotent stem cell (iPSC) technologies and proprietary, genetically engineered solutions, today ...

Add Yahoo as a preferred source to see more of our stories on Google. Modern glaucoma treatments can only preserve a patient's current level of vision, offering no hope of restoration. A new Phase 1 ...

Massive recall tally: Ford’s 2026 recalls now span 37 NHTSA campaigns covering about 10.3 million vehicles, including trucks ...

Many sessions put an emphasis on the quality and reliability of PV modules for the US market. Image: PV Tech. Industry experts, from all the sectors of the solar industry, gathered in Napa for the ...